Biotech company that provides life science research application instruments and services GenScript Biotech Corporation (SEHK:1548) announced on Thursday that it has named Dr Ross Allen Grossman as its new non-executive director and Dr Alphonse Galdes as an independent non-executive director.

Dr Grossman has more than 35 years of leadership experience in human resources across multinational financial services, pharmaceutical and biotech companies. He has served in key positions at Prudential Financial, Novartis, and UBS AG (formerly Paine Webber) and at Regeneron Pharmaceuticals. He joined GenScript in 2023 and currently serves as a consultant for Legend Biotech Corporation.

Dr Galdes extensive experience at industry leaders such as Biogen will strengthen GenScript's position in drug discovery and biopharmaceutical chemistry and manufacturing and controls (CMC) development. Dr Galdes' expertise will help drive innovation and product development, advancing GenScript's mission for high-quality growth in the biotech space.